Summit Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $117M | 6.6M | 17.84 |
| 2024-09-30 | $119M | 5.4M | 21.90 |
| 2024-06-30 | $16M | 2.0M | 7.82 |
| 2024-03-31 | $138k | 33k | 4.16 |
| 2023-12-31 | $74k | 28k | 2.64 |
| 2023-09-30 | $51k | 27k | 1.89 |
| 2023-06-30 | $60k | 24k | 2.55 |